Pills, Bills, Capitol Hill: Congrats Califf, It's All Yours
This article was originally published in Scrip
It didn't take long for the accolades to come pouring in after the US Senate on Feb. 24 in an 89-4 vote confirmed Robert McKinnon Califf as the new permanent head of the FDA – coming just over a year after he joined the agency and his predecessor, Margaret Hamburg, announced her pending departure.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.